Basic Information
Ardelyx is committed to advancing patient care through targeted, first-in-class, and novel mechanism therapies to address significant unmet medical needs. We have developed a unique and innovative platform capable of discovering new biological mechanisms and pathways to create targeted, first-in-class, orally administered small molecule therapies.
Ardelyx, Inc.
California,United States of America
101~500 people
January 01, 2007
info@ardelyx.com

